Efficacy of a Combination of Ultrasound-guided Intra-articular Injections of Hyaluronic Acid, High-power Laser Therapy and Rehabilitation on Functioning in Patients Affected by Hip Osteoarthritis.
Key facts
- Where
- Catanzaro, ItalySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Source: NCT07108400, who can take part
Where in Italy
- University Magna Graecia of CatanzaroCatanzaro, ItalyContact: Professor Alessandro de SireTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- De Sire Alessandro
- Trial code
- NCT07108400
- Record updated
- 7 August 2025
- Original description
High-power laser therapy (HPLT) is effective in treating musculoskeletal conditions, reducing pain and improving joint functionality. This randomized controlled trial (RCT) aimed to explore the effectiveness of a combination of HPLT, hyaluronic acid injections, and rehabilitation for patients with hip osteoarthritis.Read full original descriptionShow less
Efficacy of a Combination of Ultrasound-guided Intra-articular Injections of Hyaluronic Acid, High-power Laser Therapy and Rehabilitation on Functioning in Patients Affected by Hip Osteoarthritis: a Randomized Controlled Trial
High-power laser therapy (HPLT) is effective in treating musculoskeletal conditions, reducing pain and improving joint functionality. This randomized controlled trial (RCT) aimed to explore the effectiveness of a combination of HPLT, hyaluronic acid injections, and rehabilitation for patients with hip osteoarthritis.
Inclusion: Age over 18 years; Diagnosis of hip OA (stage ≤ 3 according to the Kellgren and Lawrence classification); Hip pain assessed with the Numeric Rating Scale ≥ 4; Body mass index (BMI) less than 30 kg/m²; Suspension of anti-inflammatory drugs (NSAIDs), opioids, corticosteroids, muscle relaxants or any other therapy that could interfere with the study assessments.
Exclusion: Concurrent treatment with an-ti-inflammatory drugs or rehabilitation therapies; Rheumatoid arthritis; Mini-Mental State Examination (MMSE) score < 24.